Riccardo Autorino is the Director of
Surgical Innovation and Clinical Research for the RUSH Department of Urology,
where he specializes in performing minimally invasive and robotic surgeries for
urological conditions, including prostate, kidney, and bladder cancers.
Additionally, he serves as a Professor of Urology at RUSH Medical College.
After graduating cum laude from Federico II Medical School in Napoli, Italy, he
completed his residency training in the same city, where he also obtained a Ph.D.
in Urological Sciences. In 2010, he moved to the United States, where he first
completed a two-year research fellowship in Urology and then a two-year
Clinical Fellowship in Advanced Laparoscopic and Robotic Surgery at the
Glickman Urological Institute at the Cleveland Clinic in Cleveland, Ohio. He
serves as Associate Editor for Minerva Urology, Urology Video Journal, and
Central European Journal of Urology, as well as an editorial board member for
many journals. The primary focus of his clinical practice is the management of
genitourinary cancers and benign urologic conditions, as well as their surgical
treatment using robotic-assisted surgery.
Riccardo Autorino is the Director of
Surgical Innovation and Clinical Research for the RUSH Department of Urology,
where he specializes in performing minimally invasive and robotic surgeries for
urological conditions, including prostate, kidney, and bladder cancers.
Additionally, he serves as a Professor of Urology at RUSH Medical College.
After graduating cum laude from Federico II Medical School in Napoli, Italy, he
completed his residency training in the same city, where he also obtained a Ph.D.
in Urological Sciences. In 2010, he moved to the United States, where he first
completed a two-year research fellowship in Urology and then a two-year
Clinical Fellowship in Advanced Laparoscopic and Robotic Surgery at the
Glickman Urological Institute at the Cleveland Clinic in Cleveland, Ohio. He
serves as Associate Editor for Minerva Urology, Urology Video Journal, and
Central European Journal of Urology, as well as an editorial board member for
many journals. The primary focus of his clinical practice is the management of
genitourinary cancers and benign urologic conditions, as well as their surgical
treatment using robotic-assisted surgery.